Product NDC: | 0093-2932 |
Proprietary Name: | Methyldopa |
Non Proprietary Name: | Methyldopa |
Active Ingredient(s): | 500 mg/1 & nbsp; Methyldopa |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-2932 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA070343 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090428 |
Package NDC: | 0093-2932-05 |
Package Description: | 500 TABLET, FILM COATED in 1 BOTTLE (0093-2932-05) |
NDC Code | 0093-2932-05 |
Proprietary Name | Methyldopa |
Package Description | 500 TABLET, FILM COATED in 1 BOTTLE (0093-2932-05) |
Product NDC | 0093-2932 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Methyldopa |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20090428 |
Marketing Category Name | ANDA |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | METHYLDOPA |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |